¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.
¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀåÀº 2024³â 1,404¸¸ ´Þ·¯·Î ÃßÁ¤µÇ¸ç, 2024³âºÎÅÍ 2031³â±îÁö ¿¬Æò±Õ 28.2% ¼ºÀåÇÏ¿© 2031³â¿¡´Â 8,003¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.
º¸°í¼ ¹üÀ§ |
º¸°í¼ »ó¼¼ |
±âÁØ ¿¬µµ |
2023³â |
2024³â ½ÃÀå ±Ô¸ð |
1,404¸¸ ´Þ·¯ |
½ÇÀû µ¥ÀÌÅÍ |
2019-2023³â |
¿¹Ãø ±â°£ |
2024-2031³â |
¿¹Ãø ±â°£ 2024-2031³â CAGR: |
28.20% |
2031³â °¡Ä¡ ¿¹Ãø |
8,003¸¸ ´Þ·¯ |
±×¸². GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå Á¡À¯À²(%), Áö¿ªº°, 2024³â

¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀº ¾Ï°ú °°Àº ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡¿¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. ¼¼Æ÷ Ä¡·á´Â ȯÀÚ³ª ±âÁõÀÚÀÇ ¸ö¿¡¼ ¼¼Æ÷¸¦ ÃßÃâÇÏ¿© Áúº´°ú ½Î¿ì±â À§ÇØ ¼¼Æ÷¸¦ º¯Çü½ÃŰ´Â °ÍÀ» Æ÷ÇÔÇϸç, GMP ¼Ò¸ðǰÀº ¼¼Æ÷ Ä¡·á Á¦Ç°ÀÇ °³¹ß ¹× Á¦Á¶ ½Ã ¹«±Õ¼ºÀ» º¸ÀåÇÏ°í ¿À¿°À» ¹æÁöÇϱâ À§ÇØ ¼¼Æ÷ Ä¡·á ÀýÂ÷¿¡¼ Áß¿äÇÑ ¿ªÇÒÀ» ÇÕ´Ï´Ù. ¼¼Æ÷ ±â¹Ý ¿¬±¸¿¡ ´ëÇÑ ÀÚ±Ý Áö¿ø Áõ°¡, ¸¸¼º Áúȯ¿¡ Ãë¾àÇÑ ³ëÀÎ Àα¸ Áõ°¡, ÀÇ·áºñ ÁöÃâ Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î ¼¼Æ÷ Ä¡·á¿ë GMP ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ±×·¯³ª ¼¼Æ÷ Ä¡·áÁ¦ °³¹ß°ú °ü·ÃµÈ ³ôÀº ºñ¿ë°ú GMP ½Ã¼³¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ÁöħÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.
½ÃÀå ¿ªÇÐ:
¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀåÀÇ ¼ºÀåÀº Àü ¼¼°è ¾Ï ¹× ±âŸ ¸¸¼ºÁúȯÀÇ ¹ßº´·ü Áõ°¡¿Í °°Àº ¿äÀο¡ ÀÇÇØ ÁÖµµµÇ°í ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)ÀÇ ¹ßÇ¥¿¡ µû¸£¸é 2018³â ¾ÏÀ¸·Î ÀÎÇÑ ½Å±Ô ȯÀÚ ¼ö´Â 1,810¸¸ ¸í, »ç¸ÁÀÚ ¼ö´Â 960¸¸ ¸íÀ¸·Î Áõ°¡ÇÏ¿´´Ù°í ÇÕ´Ï´Ù. ÀÌ¿¡ µû¶ó ¼¼Æ÷ Ä¡·á¿Í °°Àº ÷´Ü Ä¡·á ¼Ö·ç¼Ç¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖÀ¸¸ç, GMP ¼Ò¸ðǰ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °ø°ø ¹× ¹Î°£ ±â°üÀÇ ¼¼Æ÷ ±â¹Ý ¿¬±¸¿¡ ´ëÇÑ ÅõÀÚ È®´ë´Â ½ÃÀå ¼ºÀåÀ» ÃËÁøÇÒ ¼ö ÀÖ½À´Ï´Ù. ¿¹¸¦ µé¾î, ¹Ì±¹ ±¹¸³º¸°Ç¿ø(National Institutes of Health)Àº 2022³â±îÁö ¼¼Æ÷ Ä¡·á ¿¬±¸¿¡ 1¾ï 5,000¸¸ ´Þ·¯ ÀÌ»óÀ» ÅõÀÚÇÒ °èȹÀÔ´Ï´Ù. ±×·¯³ª ¼¼Æ÷ Ä¡·áÁ¦ °³¹ß ¹× GMP ½Ã¼³ À¯Áö¿Í °ü·ÃµÈ ³ôÀº ºñ¿ëÀÌ ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÒ ¼ö ÀÖÀ¸¸ç, GMP Á¦Á¶¿¡ ´ëÇÑ ¾ö°ÝÇÑ ±ÔÁ¦ ±âÁØÀº ¼¼Æ÷ Ä¡·áÁ¦ Á¦Ç°ÀÇ ±¤¹üÀ§ÇÑ »ó¿ëȸ¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ¼¼Æ÷ Ä¡·áÁ¦ °ü·Ã »óȯ ¹®Á¦°¡ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Á¦Á¶ °øÁ¤À» ´Ü¼øÈÇϱâ À§ÇÑ GMP ¼Ò¸ðǰÀÇ Áö¼ÓÀûÀÎ ±â¼ú ¹ßÀü°ú ¼¼Æ÷ Ä¡·áÁ¦ Àû¿ëÀÇ Áõ°¡´Â ½ÃÀå Ç÷¹À̾°Ô ¼ºÀå ±âȸ¸¦ Á¦°øÇÒ ¼ö ÀÖ½À´Ï´Ù.
º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡
ÀÌ º¸°í¼´Â ¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀåÀ» »ó¼¼È÷ ºÐ¼®ÇßÀ¸¸ç, 2023³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2024-2031³â)ÀÇ ½ÃÀå ±Ô¸ð¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR%)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.
´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¿¡ ´ëÇØ ¼³¸íÇÕ´Ï´Ù.
¶ÇÇÑ ½ÃÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù.
¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀº ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ½ÇÀû, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ÇÕ´Ï´Ù.
ÁÖ¿ä ±â¾÷Àº Merck KGaA, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific, General Electric, PBS Biotech, Meissner Filtration Products µîÀÌ ÀÖ½À´Ï´Ù.
ÀÌ º¸°í¼ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ, ½ÃÀå È®´ë ¹× ¸¶ÄÉÆÃ Àü¼ú¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖÀ» °ÍÀÔ´Ï´Ù.
¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå º¸°í¼´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ÁøÀÔÀÚ, À繫 ºÐ¼®°¡ µî ¾÷°èÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.
ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
Á¦1Àå Á¶»ç ¸ñÀû°ú °¡Á¤
Á¦2Àå ½ÃÀå Àü¸Á
Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®
- ½ÃÀå ¿ªÇÐ
- ¿µÇ⠺м®
- ÁÖ¿ä ÇÏÀ̶óÀÌÆ®
- ±ÔÁ¦ ½Ã³ª¸®¿À
- Á¦Ç° ¹ß¸Å/½ÂÀÎ
- PEST ºÐ¼®
- PORTERÀÇ ºÐ¼®
- ÀμöÇÕº´ ½Ã³ª¸®¿À
Á¦4Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå, Á¦Ç° À¯Çüº°, 2019-2023³â, (¹é¸¸ ´Þ·¯)
- ¼¼Æ÷¹è¾ç ¹èÁö¿Í º¸ÃæÁ¦
- ¼¼Æ÷ ºÐ¸® ¹× Á¤Á¦ ¼Ò¸ðǰ
- µ¿°áº¸Á¸¿ë ¼Ò¸ðǰ
- ¼¼Æ÷ µµÀÔ ¼Ò¸ðǰ
- ±âŸ ¼Ò¸ðǰ(½ÇÇè ±â±¸, ¹ÙÀÌ¿À¸®¾×ÅÍ µî)
Á¦5Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå, ¼¼Æ÷ À¯Çüº°, 2019-2023³â, (¹é¸¸ ´Þ·¯)
- Áٱ⼼Æ÷(¹è¼º, Àΰø ´Ù´É¼º, ¼ºÃ¼)
- T ¼¼Æ÷
- ÀÚ¿¬»ìÇØ(NK) ¼¼Æ÷
- ±âŸ ¼¼Æ÷ À¯Çü(¼öÁö»ó ¼¼Æ÷, ¿¬°ñ ¼¼Æ÷ µî)
Á¦6Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå, ¿ëµµº°, 2019-2023³â, (¹é¸¸ ´Þ·¯)
- Á¾¾çÇÐ
- Àç»ýÀÇ·á
- ½Å°æÇÐ
- ½ÉÇ÷°ü
- ¸é¿ªÇÐ
- ±âŸ ¿ëµµ
Á¦7Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2019-2023³â, (¹é¸¸ ´Þ·¯)
- ¹ÙÀÌ¿ÀÀǾàǰ ±â¾÷
- °è¾à Á¦Á¶ Á¶Á÷(CMO)
- ÇмúÁ¶»ç±â°ü
- º´¿ø°ú Áø·á¼Ò
- ±âŸ
Á¦8Àå ¼¼°èÀÇ GMP ¼¼Æ÷ Ä¡·á ¼Ò¸ðǰ ½ÃÀå, Áö¿ªº°, 2019-2023³â, (¹é¸¸ ´Þ·¯)
- ºÏ¹Ì
- ¶óƾ¾Æ¸Þ¸®Ä«
- À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- 秵- ¾ÆÇÁ¸®Ä«
Á¦9Àå °æÀï »óȲ
- Thermo Fisher Scientific Inc.
- Lonza Group
- Merck KGaA
- Corning Inc.
- Sartorius AG
- Danaher Corporation
- Miltenyi Biotec
- Stemcell Technologies Inc.
- GE Healthcare
- Takara Bio Inc.
- Bio-Techne Corporation
- HiMedia Laboratories
- Eppendorf AG
- Avantor, Inc.
- Beckman Coulter, Inc.
- Terumo BCT, Inc.
- Roche Diagnostics
- Irvine Scientific
- Fujifilm Irvine Scientific, Inc.
- CellGenix GmbH
Á¦10Àå ¾Ö³Î¸®½ºÆ®ÀÇ Ãßõ»çÇ×
- Wheel of Fortune
- ¾Ö³Î¸®½ºÆ®ÀÇ °ßÇØ
- Coherent Opportunity Map
Á¦11Àå Âü°í¹®Çå°ú Á¶»ç ¹æ¹ý
- Âü°í¹®Çå
- Á¶»ç ¹æ¹ý
- ÃâÆÇ»ç ¼Ò°³
ksm 24.10.23
Global GMP cell therapy consumables market is estimated to be valued at USD 14.04 Mn in 2024 and is expected to reach USD 80.03 Mn by 2031, exhibiting a compound annual growth rate (CAGR) of 28.2% from 2024 to 2031.
Report Coverage |
Report Details |
Base Year: |
2023 |
Market Size in 2024: |
US$ 14.04 Mn |
Historical Data for: |
2019 to 2023 |
Forecast Period: |
2024 to 2031 |
Forecast Period 2024 to 2031 CAGR: |
28.20% |
2031 Value Projection: |
US$ 80.03 Mn |
Figure. GMP Cell Therapy Consumables Market Share (%), By Region, 2024

Global GMP cell therapy consumables market growth is driven by increasing prevalence of chronic diseases like cancer. Cell therapy involves extracting cells from patient's/ donor's body and modifying them to fight against diseases. GMP consumables play a vital role in cell therapy procedures as these ensure sterility and prevent contamination during development and manufacturing of cell therapy products. Factors such as rising funding for cell-based research, growing geriatric population susceptible to chronic illnesses and augmenting healthcare expenditure can boost demand for GMP consumables in cell therapy globally. However, high costs associated with cell therapy developments and stringent regulatory guidelines for GMP facilities can hamper the market growth.
Market Dynamics:
Global GMP cell therapy consumables market growth is driven by factors such as rising incidence of cancer and other chronic illnesses worldwide. As per WHO, cancer burden has increased to 18.1 million new cases and 9.6 million deaths in 2018. This has boosted demand for advanced treatment solutions like cell therapy, thus, boosting the need for GMP consumables. Growing investments in cell-based research by public-private organizations can drive the market growth. For instance, National Institutes of Health granted over US$ 150 million towards cell therapy research in 2022. However, high costs associated with cell therapy development and maintenance of GMP facilities can hamper the market growth. Strict regulatory standards for GMP manufacturing can hamper the wider commercialization of cell therapy products. Moreover, reimbursement issues related to cell therapies can hamper the market growth. Ongoing technological advancements in GMP consumables to simplify manufacturing processes and rising applications of cell therapies can provide growth opportunities for market players.
Key features of the study:
This report provides in-depth analysis of the global GMP cell therapy consumables market, and provides market size (USD Million) and compound annual growth rate (CAGR%) for the forecast period (2024-2031), considering 2023 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global GMP cell therapy consumables market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Merck KGaA, Danaher Corporation, Sartorius AG, Thermo Fisher Scientific, General Electric, PBS Biotech, Meissner Filtration Products
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
Global GMP cell therapy consumables market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global GMP cell therapy consumables market
Detailed Segmentation-
- Product Type Insights (Revenue, USD Mn, 2019 - 2031)
- Cell Culture Media and Supplements
- Cell Separation and Purification Consumables
- Cryopreservation Consumables
- Cell Transduction Consumables
- Other Consumables (Labware, Bioreactors, etc.)
- Cell Type Insights (Revenue, USD Mn, 2019 - 2031)
- Stem Cells (Embryonic, Induced Pluripotent, Adult)
- T-Cells
- Natural Killer (NK) Cells
- Other Cell Types (Dendritic Cells, Chondrocytes, etc.)
- Application Insights (Revenue, USD Mn, 2019 - 2031)
- Oncology
- Regenerative Medicine
- Neurology
- Cardiovascular
- Immunology
- Other Applications
- End User Insights (Revenue, USD Mn, 2019 - 2031)
- Biopharmaceutical Companies
- Contract Manufacturing Organizations (CMOs)
- Academic and Research Institutions
- Hospitals and Clinics
- Others
- By Regional Insights (Revenue, USD Mn 2019 - 2031)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Thermo Fisher Scientific Inc.
- Lonza Group
- Merck KGaA
- Corning Inc.
- Sartorius AG
- Danaher Corporation
- Miltenyi Biotec
- Stemcell Technologies Inc.
- GE Healthcare
- Takara Bio Inc.
- Bio-Techne Corporation
- HiMedia Laboratories
- Eppendorf AG
- Avantor, Inc.
- Beckman Coulter, Inc.
- Terumo BCT, Inc.
- Roche Diagnostics
- Irvine Scientific
- Fujifilm Irvine Scientific, Inc.
- CellGenix GmbH
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global GMP Cell Therapy Consumables Market, By Product Type
- Global GMP Cell Therapy Consumables Market, By Cell Type
- Global GMP Cell Therapy Consumables Market, By Application
- Global GMP Cell Therapy Consumables Market, By End User
- Global GMP Cell Therapy Consumables Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
4. Global GMP Cell Therapy Consumables Market, By Product Type, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Cell Culture Media and Supplements
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cell Separation and Purification Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cryopreservation Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cell Transduction Consumables
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Other Consumables (Labware, Bioreactors, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
5. Global GMP Cell Therapy Consumables Market, By Cell Type, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Stem Cells (Embryonic, Induced Pluripotent, Adult)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- T-Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Natural Killer (NK) Cells
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Other Cell Types (Dendritic Cells, Chondrocytes, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
6. Global GMP Cell Therapy Consumables Market, By Application, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020- 2031
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Regenerative Medicine
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Neurology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Cardiovascular
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Immunology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Other Applications
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
7. Global GMP Cell Therapy Consumables Market, By End User, 2019-2031, (USD Mn)
- Introduction
- Market Share Analysis, 2024 and 2031 (%)
- Y-o-Y Growth Analysis, 2020 - 2031
- Segment Trends
- Biopharmaceutical Companies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Contract Manufacturing Organizations (CMOs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Academic and Research Institutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Hospitals and Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2019-2031, (USD Mn)
8. Global GMP Cell Therapy Consumables Market, By Region, 2019 - 2031, (USD Mn)
- Introduction
- Market Share (%) Analysis, 2024,2027 & 2031, (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2019 - 2031, (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country, 2019 - 2031, (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Cell Type, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Application, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By End User, 2019 - 2031, (USD Mn)
- Market Size and Forecast, By Country/Region, 2019 - 2031, (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Thermo Fisher Scientific Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck KGaA
- Corning Inc.
- Sartorius AG
- Danaher Corporation
- Miltenyi Biotec
- Stemcell Technologies Inc.
- GE Healthcare
- Takara Bio Inc.
- Bio-Techne Corporation
- HiMedia Laboratories
- Eppendorf AG
- Avantor, Inc.
- Beckman Coulter, Inc.
- Terumo BCT, Inc.
- Roche Diagnostics
- Irvine Scientific
- Fujifilm Irvine Scientific, Inc.
- CellGenix GmbH
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us